Publications by authors named "Steven H Chin"

Claim this Profile
A
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Carolyn D Britten, Elizabeth Garrett-Mayer, Steven H Chin, Keisuke Shirai, Besim Ogretmen

Clin Cancer Resยท August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis